Brief: Prostalund CoreTherm Passes Efficacy And Safety Evaluation By "Nye Metoder" In Norway
June 24 (Reuters) - ProstaLund AB PLUND.ST :
* PROSTALUND´S CORETHERM® HAS PASSED THE EFFICACY AND SAFETY
EVALUATION BY "NYE METODER" IN NORWAY
Source text for Eikon: ID:nMFN5gFLLh
Further company coverage: PLUND.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on ProstaLund AB
See all newsBrief: ProstaLund 9M Operating Profit SEK -14 Million
Brief: Prostalund Applies For Delisting From Nasdaq Stockholm
Brief: ProstaLund Takes Out Loan Of SEK 4 Mln From Two Largest Shareholders
Brief: ProstaLund Enters Collaboration Agreement With The XEN Group
Brief: Prostalund Enters Collaboration With Mayumana Healthcare